uniQure

UniQure’s hemophilia B gene therapy achieves 31% FIX activity
UniQure’s hemophilia B gene therapy achieves 31% FIX activity
Fierce Biotech
uniQure
hemophilia B
gene therapy
FIX-Padula
Flag link:
Who will pay for CRISPR?
Who will pay for CRISPR?
Stat
CRISPR
gene therapy
uniQure
Editas
Spark Therapeutics
Flag link:
Biotech firm pulls pioneering gene therapy due to no demand
Biotech firm pulls pioneering gene therapy due to no demand
Yahoo/Reuters
uniQure
gene therapy
Glybera
Flag link:
Shire cans Baxalta hemophilia B gene therapy, thinning field for uniQure, Spark
Shire cans Baxalta hemophilia B gene therapy, thinning field for uniQure, Spark
Fierce Biotech
Shire
Baxalta
hemophilia B
gene therapy
BAX 335
Spark Therapeutics
uniQure
Flag link:
Positive hemophilia B gene-therapy results boost UniQure stock
Positive hemophilia B gene-therapy results boost UniQure stock
BioPharma Dive
uniQure
hemophilia B
Flag link:
UniQure's Gene Therapy Boosts Clotting in Two Hemophiliacs
UniQure's Gene Therapy Boosts Clotting in Two Hemophiliacs
Bloomberg
uniQure
gene therapy
hemophilia B
AMT-060
Flag link:
Positive Topline Results Announced From Phase I/II Trial in Sanfilippo B Syndrome Patients Using uniQure's Novel AAV5-Based Gene Therapy
Positive Topline Results Announced From Phase I/II Trial in Sanfilippo B Syndrome Patients Using uniQure's Novel AAV5-Based Gene Therapy
Yahoo
uniQure
gene therapy
Flag link:
FDA demands another study for uniQure's ultra-pricey gene therapy
FDA demands another study for uniQure's ultra-pricey gene therapy
BioPharma Dive
FDA
uniQure
gene therapy
lipoprotein lipase deficiency
Glybera
Flag link:
The 5 Most Expensive Drugs in the World in 2015
The 5 Most Expensive Drugs in the World in 2015
Motley Fool
drug pricing
Glybera
Soliris
Naglazyme
Vimizim
Elaprase
Shire
Biomarin
Alexion
uniQure
Flag link:
UniQure plans $100M follow-on offering in afterglow of big-ticket Bristol deal
UniQure plans $100M follow-on offering in afterglow of big-ticket Bristol deal
Fierce Biotech
uniQure
Bristol-Myers Squibb
M&A
Flag link:
Bristol-Myers buys into Dutch gene therapy company uniQure
Bristol-Myers buys into Dutch gene therapy company uniQure
Yahoo/Reuters
Bristol-Myers Squibb
uniQure
gene therapy
Flag link:
UniQure bets on a gene therapy for heart failure
UniQure bets on a gene therapy for heart failure
Fierce Biotech
uniQure
congestive heart failure
AAV-S100A1
Flag link:
Gene Therapy's Big Comeback
Gene Therapy's Big Comeback
Forbes
gene therapy
Bristol-Myers Squibb
Bluebird Bio
NightstaRx
Voyager Therapeutics
uniQure
Celladon
Juno Therapeutics
Editas Medicine
Gensight Biologics
Audentes Therapeutics
Dimension Therapeutics
Flag link:
IPO boom: 8 biotechs bag half a billion in a banner week
IPO boom: 8 biotechs bag half a billion in a banner week
Fierce Biotech
IPOs
Argos Therapeutics
Eleven Biotherapeutics
Revance Therapeutics
Egalet
uniQure
Auspex Pharmaceuticals
Genocea Biosciences
Biocept
Flag link:
Eager biotechs crowd into Wall Street this week with $500M in IPO pitches
Eager biotechs crowd into Wall Street this week with $500M in IPO pitches
Fierce Biotech
IPOs
biotechs
uniQure
ReVance
Eleven Biotherapeutics
Flag link:
FierceBiotech's 2013 Fierce 15
FierceBiotech's 2013 Fierce 15
Fierce Biotech
biotech
AnaptysBio
Acetylon Pharmaceuticals
CytomX
Immunocore
FibroGen
Jounce Therapeutics
Kala Pharmaceuticals
Macrogenics
Moderna Therapeutics
Presage Biosciences
Nimbus Discovery
Scioderm
Ultragenyx
uniQure
Visterra
Flag link:
UniQure’s Glybera Wins EU Backing As First Gene Therapy
UniQure’s Glybera Wins EU Backing As First Gene Therapy
Bloomberg
uniQure
Glybera
Flag link: